FDA enlists companies to head off drug shortages

The Food and Drug Administration is announcing a new proposal designed to head off more shortages of crucial medications that have disrupted care at hospitals and health clinics nationwide.

Under the proposed rule, companies that make widely-used prescription medicines would have to notify the FDA of any changes in drug production that could disrupt the U.S. supply.

FDA leaders say the advance warning will help the agency work with companies to resolve supply problems or find alternate sources of drugs that are being phased out.

The U.S. has seen a spike in over the past six years, particularly inexpensive generic injected drugs, including powerful antibiotics, painkillers and anesthetics used in surgery. They are the workhorses of hospitals but often produce little profit for companies.


Explore further

Fear in US as drug shortages mount

© 2013 The Associated Press. All rights reserved.

Citation: FDA enlists companies to head off drug shortages (2013, October 31) retrieved 8 March 2021 from https://medicalxpress.com/news/2013-10-fda-companies-drug-shortages.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments